Perrigo (PRGO) Non-Current Assets (2013 - 2026)

Perrigo's (PRGO) quarterly Non-Current Assets came in at $5.3 billion in Q1 2026, down 27.06% year-on-year from $7.2 billion in Q1 2025, and down 8.14% on a QoQ basis from $5.7 billion in Q4 2025.

Perrigo (PRGO) Non-Current Assets (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Non-Current Assets data on file, last reported at $5.3 billion in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 27.06% year-over-year to $5.3 billion in Q1 2026; TTM through Mar 2026 was $5.3 billion, a 27.06% decrease from a year earlier, with the FY2025 full-year figure at $5.7 billion, down 19.93% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $5.3 billion, down from $5.7 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for PRGO reached as high as $8.3 billion in Q4 2022 and fell as low as $5.3 billion in Q1 2026.
  • Historically, Non-Current Assets has averaged $7.4 billion across 5 years, with a median of $7.5 billion in 2024.
  • Across the five-year window, Non-Current Assets grew 27.27% in 2023 and retreated 27.06% in 2026, its largest moves.
  • Year by year, Non-Current Assets stood at $8.3 billion in 2022, then declined by 3.87% to $8.0 billion in 2023, then declined by 10.16% to $7.2 billion in 2024, then retreated by 19.93% to $5.7 billion in 2025, then slipped by 8.14% to $5.3 billion in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $5.3 billion in Q1 2026, $5.7 billion in Q4 2025, and $7.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn 5.27 Bn

Historic Data

Download Data
DateValue
Mar 28, 2026 5.27 Bn
Dec 31, 2025 5.74 Bn
Sep 27, 2025 7.20 Bn
Jun 28, 2025 7.48 Bn
Mar 29, 2025 7.23 Bn
Dec 31, 2024 7.17 Bn
Sep 28, 2024 7.50 Bn
Jun 29, 2024 7.44 Bn
Mar 30, 2024 7.83 Bn
Dec 31, 2023 7.98 Bn
Sep 30, 2023 7.99 Bn
Jul 1, 2023 8.19 Bn
Apr 1, 2023 8.21 Bn
Dec 31, 2022 8.30 Bn
Oct 1, 2022 8.09 Bn
Jul 2, 2022 8.27 Bn
Apr 2, 2022 6.45 Bn
Dec 31, 2021 6.57 Bn
Oct 2, 2021 6.69 Bn
Jul 3, 2021 6.81 Bn